|Bid||1.750 x 4500|
|Ask||1.760 x 1200|
|Day's Range||1.720 - 1.770|
|52 Week Range||1.350 - 8.000|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 6, 2018 - Mar 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.79|
Trevena Inc. shares jumped in the extended session Tuesday after the biotech company said the Food and Drug Administration accepted for review a marketing application for its opioid-replacement painkiller. ...
CHESTERBROOK, Pa., Jan. 02, 2018-- Trevena, Inc. today announced that the U.S. Food and Drug Administration has accepted the Company’ s New Drug Application for OLINVO™ Injection. The Company expects that ...
CHESTERBROOK, Pa., Nov. 02, 2017-- Trevena, Inc. today announced that it has recently submitted its New Drug Application for OLINVO TM to the U.S. OLINVO is the first G protein biased ligand of the mu ...
CHESTERBROOK, Pa., Nov. 01, 2017-- Trevena, Inc. today announced that it will host a conference call and webcast on Tuesday, November 7, 2017 at 8:00 am EST to review financial results for the quarter ...